Ibrutinib inhibits CD20 up-regulation on CLL B cells mediated by the CXCR4/SDF-1 AXIS.
Authors | |
---|---|
Year of publication | 2016 |
Type | Conference abstract |
MU Faculty or unit | |
Citation | |
Related projects: |
|
Authors | |
---|---|
Year of publication | 2016 |
Type | Conference abstract |
MU Faculty or unit | |
Citation | |
Related projects: |
|